Phase 2 Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are scheduled to receive a specific type of liver-targeted radiation treatment (called TARE) for liver cancer that has not been treated before and can be seen on an ultrasound scan.
- You are at least 18 years old.
- You are in a generally stable condition of health.
- If you are a woman who could become pregnant, you must have a negative pregnancy test.
- You have read, understood, and signed a consent form agreeing to take part in the study.
Who may not be able to join:
- You are in an unstable, seriously ill, or terminally ill condition, or your health situation is difficult to predict.
- You have a known allergy or sensitivity to any of the ingredients in a contrast agent called Lumason (used during ultrasound).
- You have a known allergy or sensitivity to any of the ingredients in a contrast agent called Sonazoid (used during ultrasound).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Tumor viability on contrast enhanced ultrasound using a blood pooling contrast agent; Tumor viability on contrast enhanced ultrasound using a blood pooling contrast agent
Can't join this trial?
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.